JSC "BelVitunifarm" thwart the plans of implementation of an investment project worth more than Br19 billion. This was at a joint session of the State Control Committee and the Prosecutor's Office of Vitebsk region on the effectiveness of plans to modernize and use of equipment the deputy chairman of the regional SCC Julia Avhukova.

"BelVitunifarm" not implemented the project of production of pharmaceuticals included in the list of major investment projects. It invested more than Br19 billion: renovated industrial building, most of the area which is now empty, in 2010 purchased packaging line cost Br2,5 billion. During this time it is used by only 2% of the notional capacity. Standard life line (7 years) will expire in two years.

Inherent in the business plan forecasts on volumes of production and sales did not materialize. Amounts owed to Jordan pharmaceutical company (one of the founders of) – Br7 billion. Planned for the production of 50 types of medicines utilized only 4. In addition, packaged drugs were not sold, as a result the shelf life of more than 40 thousand. Packages expired in 2014.

Also in 2010, through a loan was purchased laboratory equipment worth Br168 million, which since the acquisition is not used. As a result of the plan to involve the share of state property into economic circulation is still not clear, added Julia Avhukova.

Venture for the development and production of veterinary drugs established in 1930 as the Vitebsk Biofabrika. From 2006 to 2010, was reconstructed industrial complex, resulting in the factory claim the title of sole proprietorships biological industry in Belarus, which specializes in the production of complex medical and diagnostic products for the needs of veterinary medicine. In 2012 Vitebsk Biofabrika was reorganized into OJSC "BelVitunifarm".

BELTA